ENTRY       D03489                      Drug
NAME        Cicloprofen (USAN/INN)
FORMULA     C16H14O2
EXACT_MASS  238.0994
MOL_WEIGHT  238.2812
CLASS       Anti-inflammatory
             DG01504  Nonsteroidal anti-inflammatory drug (NSAID)
              DG01908  Anti-inflammatory drug, propionic acid derivatives
EFFICACY    Anti-inflammatory
INTERACTION  
BRITE       Drug groups [BR:br08330]
             Anti-inflammatory
              DG01504  Nonsteroidal anti-inflammatory drug (NSAID)
               DG01908  Anti-inflammatory drug, propionic acid derivatives
                D03489  Cicloprofen
DBLINKS     CAS: 36950-96-6
            PubChem: 17397625
            LigandBox: D03489
            NIKKAJI: J19.780G
ATOM        18
            1   C8y C    19.3200   -9.8700
            2   C8y C    19.3200  -11.2700
            3   C8y C    21.7449  -11.2700
            4   C8y C    21.7449   -9.8700
            5   C1x C    20.5324   -9.1700
            6   C8x C    22.9573  -11.9700
            7   C8x C    24.1697  -11.2700
            8   C8y C    24.1697   -9.8700
            9   C8x C    22.9573   -9.1700
            10  C8x C    18.1076   -9.1700
            11  C8x C    16.8951   -9.8700
            12  C8x C    16.8951  -11.2700
            13  C8x C    18.1076  -11.9700
            14  C1c C    25.3624   -9.1700
            15  C6a C    26.5749   -9.8700
            16  O6a O    27.7873   -9.1700
            17  C1a C    25.3574   -7.7701
            18  O6a O    26.5749  -11.2698
BOND        20
            1     1   2 1
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     1   5 1
            6     3   6 1
            7     6   7 2
            8     7   8 1
            9     8   9 2
            10    4   9 1
            11    1  10 2
            12   10  11 1
            13   11  12 2
            14   12  13 1
            15   13   2 2
            16    8  14 1
            17   14  15 1
            18   15  16 1
            19   14  17 1
            20   15  18 2
///
